Myovant Sciences Ltd. MYOV
Set alert
26.98 +26.98 —
Day range unavailable
52-week range unavailable
- Open
- —
- Prev close
- 0.00
- Mkt cap
- 2.62B
- Vol
- 0
- Avg vol
- 0
- EPS
- 0.00
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- —
- High
- —
- Forward P/E
- -26.19
- Beta
- 2.15
- Short ratio
- 11.21
- Inst. own
- 56.21%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Jan 26, 2023
- 50-d avg
- 26.92
- 200-d avg
- 21.54
- 1y target
- 27.00
Financial health
Altman Z-Score
-2.96 Distress zone
Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.
Piotroski F-Score
2 / 9 Weak
Nine pass/fail tests of profitability, leverage and efficiency.
Valuation
P/E -6.0×
FY 2016 5y median -6.0× FY 2022
P/S 5.4×
FY 2016 5y median 0.0× FY 2022
P/B -2.6×
FY 2016 5y median -2.6× FY 2022
P/FCF -4.6×
FY 2016 5y median -4.6× FY 2022
EV/EBITDA -6.5×
FY 2016 5y median -6.4× FY 2022
EV/Sales 5.2×
FY 2016 5y median 0.0× FY 2022
FCF Yield -21.8%
FY 2016 5y median -14.2% FY 2022
Profitability
Gross Margin 77.7%
FY 2016 5y median 0.0% FY 2022
Operating Margin -81.1%
FY 2016 5y median 0.0% FY 2022
Net Margin -89.2%
FY 2016 5y median 0.0% FY 2022
ROE 43.5%
FY 2016 5y median 43.5% FY 2022
ROIC -68.9%
FY 2016 5y median -172.0% FY 2022
ROA -39.6%
FY 2016 5y median -120.3% FY 2022
Growth (YoY)
Revenue 289.4%
FY 2016 FY 2022
Operating Income 28.2%
FY 2016 FY 2022
EPS (diluted) 21.6%
FY 2016 FY 2022
Free Cash Flow -173.1%
FY 2016 FY 2022
Financial Health
Current Ratio 2.0×
FY 2016 5y median 2.3× FY 2022
Quick Ratio 1.9×
FY 2016 5y median 2.3× FY 2022
Debt / Equity -0.8×
FY 2016 5y median -0.8× FY 2022
Net Debt / EBITDA 0.2×
FY 2016 5y median 0.2× FY 2022
Interest Coverage -13.4×
FY 2016 5y median -25.1× FY 2022
Dividends
Dividend Yield 0.0%
FY 2016 5y median 0.0% FY 2022
Payout Ratio 0.0%
FY 2016 5y median 0.0% FY 2022
Annual · latest fiscal year ends 2022-03-31